Closed transaction

Scent

Michael Ilan
Deal stage
Closed transaction
Service
Buy
Sector
Healthcare
Sub-sector
Other Healthcare
Contact
sam@genesiscf.com

Description

SCENT has developed a revolutionary game-changing solution using extremely sensitive biosensors – trained laboratory mice – for the early detection of breast and lung cancer by the smell of bodily odors

Deal team

Members of this deal.

More from this adviser

Other deals by Genesis Investment Consultants.

View firm

More in this sector

More deals in the Healthcare sector.

View deals

Deal announcement

Buy-side advisory

Confidential. We are pitching for a Buy-side mandate: an Indian plant-extract ingredients company wants to buy profitable extract makers or distributors in the US, Europe…

→

Deal announcement

Sell-side advisory

VPD Bled d.o.o.. Company specialized in Wholesale Distribution & Retail of Medical Devices, offering a broad portfolio of healthcare products across respiratory care, blood pressure monitoring, rehabilitation,…

→

Deal announcement

Sell-side advisory

Undisclosed. We are pitching for the sale of a UK-based manufacturer and supplier of high-quality single-use surgical instruments and devices

→

View our deals

Explore transactions

Get in touch

Find an adviser.

Contact us